Related Experiment Video
Updated: May 16, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
Overactive bladder syndrome - management and treatment options
Janine Arnold1, Nicholas McLeod, Ruban Thani-Gasalam
1Department of Surgery, Bendigo Hospital, Victoria. janine.arnold@optusnet.com.au
Overactive bladder syndrome, affecting 12-17% of the population, causes urinary urgency and frequency. Management starts with lifestyle changes and progresses to advanced therapies if needed.
Area of Science:
- Urology
- General Practice
- Internal Medicine
Background:
- Overactive bladder syndrome (OAB) is a clinical diagnosis characterized by urinary urgency, frequency, and nocturia.
- Symptoms of OAB can include urge urinary incontinence and are often manageable in primary care settings.
Purpose of the Study:
- To provide a comprehensive review of overactive bladder syndrome.
- To offer management guidance for general practitioners (GPs) in primary care.
Main Methods:
- Literature review on overactive bladder syndrome.
- Synthesis of current diagnostic and management strategies.
Main Results:
- OAB affects 12-17% of the population, with prevalence increasing with age.
- Initial management involves excluding underlying pathology and implementing conservative treatments.
- Conservative treatments include lifestyle modifications, pelvic floor exercises, bladder training, and antimuscarinic agents.
Conclusions:
- Failure of conservative OAB management requires referral to a urologist.
- Second-line therapies for refractory OAB include botulinum toxin injections, neuromodulation, and surgical options.
- Effective management of OAB is crucial for improving patients' quality of life.
Related Concept Videos
Irritable Bowel Syndrome III: Medical and Nursing Management
Urinary Tract Infection IV: Nursing Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi III: Medical Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
